121 articles - From Friday Sep 25 2026 to Friday Oct 02 2026
Guidelines and related publications, position statements, white papers, technical reviews, consensus statements, etc…
| Am J Gastroenterol |
|---|
| Serrated Polyposis Syndrome: A Review and Consensus Statement by the US Multi-Society Task Force on Colorectal Cancer.
Germline genetic testing is indicated only in individuals who meet criteria for a known hereditary syndrome in the appropriate clinical setting. First-degree relatives of patients with SPS are at heightened risk of CRC and should undergo colonoscopic screening. |
| Clin Gastroenterol Hepatol |
| AGA Clinical Practice Update on Surveillance of Pancreatic Cystic Lesions and Hepatocellular Carcinoma in Older Adults: Expert Review.
BEST PRACTICE ADVICE 9: HCC surveillance should stop if estimated life expectancy is low and is less than 1 to 2 years based on medical comorbidities, impaired functional status, or liver decompensation (eg, Child-Turcotte-Pugh C cirrhosis) where liver transplant is not an option. Shared decision-making with patients can inform HCC surveillance decisions. |
| Endoscopy |
| Curriculum for endoscopic treatment of esophageal neoplasia and precursor lesions: ESGE Position Statement - with competency assessment tools.
Ideally, a minimum of 10 supervised cases should be done on ex vivo/in vivo models. Abstract In order to maintain competence in the endoscopic management of early esophageal neoplasia, an annual caseload of at least 10 new cases per endoscopist with esophageal endoscopic resection and 10 new cases per endoscopist with endoscopic ablation is required. |
| Gastroenterology |
| Serrated Polyposis Syndrome: A Review and Consensus Statement by the US Multi-Society Task Force on Colorectal Cancer.
Germline genetic testing is indicated only in individuals who meet criteria for a known hereditary syndrome in the appropriate clinical setting. First-degree relatives of patients with SPS are at heightened risk of CRC and should undergo colonoscopic screening. |
| Gastrointest Endosc |
| American Society for Gastrointestinal Endoscopy guideline on management of esophageal and gastric varices in patients with cirrhosis. |
| Serrated Polyposis Syndrome: A Review and Consensus Statement by the US Multi-Society Task Force on Colorectal Cancer.
Germline genetic testing is indicated only in individuals who meet criteria for a known hereditary syndrome in the appropriate clinical setting. First-degree relatives of patients with SPS are at heightened risk of CRC and should undergo colonoscopic screening. |
| Gut |
| EUropean consensus on the Resolution Of SympToms After oesophago-gastric Resection (EUROSTAR): Peri-Operative Quality Initiative (POQI) consensus statement.
The EUROSTAR consensus provides guidance on symptom monitoring, service provision and the investigation and management of common postoperative conditions following UGI cancer surgery. These recommendations represent an important step towards standardising survivorship care and supporting future research in this patient population. |
| Expert consensus on clinical trials for use of systemic therapy in patients with hepatocellular carcinoma undergoing surgical and locoregional therapies.
Optimal design of HCC trials is important to rigorously evaluate the role of systemic therapy in patients undergoing surgical resection or in combination with locoregional therapy. |
| J Hepatol |
| EASL-EASD-EASO Guidance for the Use of Resmetirom and Semaglutide as MASH-Targeted Therapy.
Ongoing studies are evaluating long-term effectiveness of both agents to reduce MALO. In adults with MASH cirrhosis, resmetirom or semaglutide appear safe but should not be used as MASH-targeted treatment, until further data establish liver-related benefits. |
meta-analyses and systematic reviews
| Aliment Pharmacol Ther |
|---|
| Meta-Analysis: The Placebo Response in Modern Treatments for Cholestatic Pruritus: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
The magnitude of placebo-associated improvement differed across outcome instruments and may affect estimates and interpretation of treatment effects in cholestatic-pruritus trials. These findings may inform endpoint selection and assumptions used in future trial design. |
| Systematic Review: Inclusion of Patients With Difficult-to-Treat Inflammatory Bowel Disease in Randomized Controlled Trials of Advanced Therapies.
Few RCTs of advanced medications include patients with DTT-IBD. In most trials, participants with DTT-IBD represent a minority of the study population, and subgroup-specific data are lacking. |
| Clin Gastroenterol Hepatol |
| Gastric and Duodenal Cancer in Lynch Syndrome: Incidence and Endoscopic Surveillance-Systematic Review and Meta-analysis.
LS is associated with clinically relevant GC and DC incidence, with risk varying by MMR gene. Current comparative evidence for EGD surveillance is limited and observational. These findings support further evaluation of risk-adapted upper endoscopic surveillance, but do not establish reduced cancer incidence or survival benefit. |
| Managing IBS-Like Symptoms in Quiescent Inflammatory Bowel Disease: A Meta-Analysis of Randomized Trials.
Current evidence does not support a definitive benefit for any single intervention class in the management of IBS-like symptoms in quiescent IBD. Although dietary interventions demonstrated the largest point estimate for symptom improvement, the evidence remained highly uncertain because of imprecision and risk of bias. Larger, rigorously designed blinded trials using standardized endpoints are needed to define effective symptom-directed therapies. |
RCT, clinical trials, retrospective studies, etc…
| Aliment Pharmacol Ther |
|---|
| Accelerated Biological Aging in Cholestatic Liver Disease: Telomere Attrition and Association With Disease Severity.
Cholestatic liver diseases are associated with shortened DNAmTL, which independently correlates with disease severity in PSC. Together with epigenetic age acceleration, these findings support a model of accelerated biological aging in PSC and PBC characterized by converging signatures of accelerated biological aging that may contribute to progressive biliary injury and fibrosis. |
| Clinical trial: The Effect on Intragastric pH and Pharmacokinetics of the PCAB Linaprazan Glurate in Healthy Subjects After Repeat-Dose Administration for up to 14 Days.
Mean AUC and mean C increased in proportion to LG dose. LG was safe and well tolerated at the studied dose levels. |
| Pathogen-Specific Bloodstream Infections Associated With Tumour Necrosis Factor-α Inhibitors, Vedolizumab and Ustekinumab in Inflammatory Bowel Disease: A Danish Nationwide Case-Control Study 2010-2024.
TNFi use was associated with increased BSI rates in patients with IBD, whereas vedolizumab and ustekinumab use was not. Overall, the findings suggest potential differences in infection risk across biologic therapies and in pathogen-specific susceptibility. |
| Persistence, Safety and Pharmacokinetics of Vedolizumab After Switching to the Subcutaneous Route in a Prospective French National Cohort Study.
In this multicentric cohort, the persistence at 1 year from switch to SC-VDZ in IBD patients was 84%. |
| Revisiting Ferritin-IgG Score to Predict Complete Biochemical Response in Autoimmune Hepatitis.
The ferritin-IgG score failed external validation in an independent multicentre cohort. Ferritin showed no prognostic value, whereas the predefined IgG threshold retained its ability to predict treatment response. |
| Clin Gastroenterol Hepatol |
| Altered cognition and patient-reported outcomes predict 1-year hospitalization risk in a multi-center outpatient cirrhosis cohort.
In an outpatient cohort with etiology-controlled cirrhosis with a median MELD of 11, one-third required non-elective hospitalization by 1-year. PROs using SF-36 and cognitive performance measured by Stroop were independently additive to clinical parameters to predict future risk of all-cause, liver-related and HE-related hospitalization. Routine assessment of cognition and PROs could improve holistic outpatient management and prognostication in cirrhosis. |
| Characterizing the Benefits of Serial Ascitic Fluid Testing in Ambulatory Patients with Cirrhosis: A National Cohort Study.
Ascitic fluid testing practices for outpatient paracentesis vary substantially and are associated with differences in outcomes. Universal testing was associated with lower short-term hospitalization and mortality among patients with higher CTP scores, although these observational findings may reflect differences in patient selection and care delivery. Evaluation of standardized, risk-adapted testing protocols is warranted. |
| Clinical and oncological outcomes of gastroduodenal neuroendocrine tumours after endoscopic resection in the Western setting - a target trial emulation.
GD-NETs were associated with frequent non-curative ER resections, but low recurrence and tumour-related mortality. ESD achieved a higher adjusted R0 resection rate and lower local recurrence compared with C-EMR. These results support the refinement of not only the curative resection criteria but also patient and ER technique selection. |
| Effectiveness of Medical-Behavioral Therapy in Patients with Fecal Incontinence.
Among patients with moderate-to-severe FI, 23% and 15% responded to MBT at 1 and 3 months. Responses at 3-months were clinically meaningful, associated with improved QoL, and more likely in patients with higher baseline FI frequency, and no visible external sphincter defects. |
| Extrahepatic Autoimmune Disease in People With Primary Biliary Cholangitis: Nationwide Occurrence and Relation to Outcome.
In a nationwide population of individuals with PBC, EHAIDs are common. EHAIDs were mostly present at baseline and were not associated with long-term clinical outcome. As symptoms in people with PBC may be aggregated or caused by concurrent EHAIDs, this study is important to improve the awareness and evaluation of EHAIDs in PBC. |
| IMPROVED SEVERITY AND QUALITY-OF-LIFE MEASURES FOR FECAL INCONTINENCE: DEVELOPMENT OF THE MINNESOTA (MiNi)-FISI AND MiNi-FI-QOL.
The MiNi-FISI and MiNi-FI-QoL are concise, psychometrically derived short forms with strong performance across diverse cohorts. Further validation, including direct patient input to confirm content validity, is warranted. |
| Upadacitinib Is Associated with the Lowest Risk of Treatment Failure Among Advanced Therapies for Ulcerative Colitis: A Real-World Administrative Claims Study.
In this large real-world UC cohort, upadacitinib was associated with the lowest risk of treatment failure and greatest corticosteroid-free disease stability compared with al other ATs evaluated. |
| Endoscopy |
| Plastic Stent-Based Management Versus Metal Stent Exposure for Lifelong Biliary Drainage in Unresectable Malignant Hilar Biliary Obstruction.
SEMS exposure was associated with higher odds of LDF and higher costs than PS-based management. These findings are hypothesis-generating, and prospective studies are needed to determine whether routine first-line SEMS use should be reconsidered when biliary drainage is intended to last across the remaining disease course. |
| Gastroenterology |
| An Unexpected Cause of Severe Steatohepatitis in a Young Male.
Abdominal ultrasonography performed in December 2025 revealed heterogeneous liver echotexture with diffuse nodular hyperechoic areas, initially suggestive of nodular fatty infiltration or cirrhosis, and was accompanied by mild splenomegaly. Contrast-enhanced abdominal computed tomography (CT) demonstrated the following findings (Figure A). |
| Dietary modulation of intestinal microbes prolongs survival in a Hirschsprung disease mouse model.
These observations suggest for the first time to our knowledge that dietary interventions (other than breastfeeding) might prevent Hirschsprung disease-associated enterocolitis. |
| Gastrointest Endosc |
| Clinical outcomes of endoscopic submucosal dissection for previously treated superficial non-ampullary duodenal epithelial tumors.
Despite a relatively high rate of residual lesions following ESD for previously treated SNADETs, ESD was feasible, and al patients ultimately achieved clinical success. ESD for previously treated SNADETs may represent a reasonable treatment option. |
| Clinical outcomes of incomplete diverticular inversion after endoscopic band ligation for colonic diverticular bleeding.
Incomplete inversion after EBL was associated with higher odds of 30-day rebleeding than complete inversion. Thirty-day rebleeding rates exceeded one-third in both the incomplete-inversion and indirect-clipping groups, but the exploratory comparison was inconclusive. |
| Radiofrequency ablation versus hybrid argon plasma coagulation for dysplastic Barrett's esophagus: a randomized-controlled trial assessing procedural tolerability and safety (RATE study).
Compared with RFA, h-APC was associated with a lower postprocedural pain and dysphagia burden and numerically fewer post-ablation strictures, while achieving similar eradication rates of dysplastic Barrett's esophagus. |
| Gut |
| Butyrylcholinesterase alleviates hepatic stellate cell activation via paracrine muscarinic signalling.
Hepatocyte injury disrupts BuChE activity, causing local ACh accumulation and subsequent HSC activation via ChRM3 signalling. This newly identified cholinergic circuit drives fibrosis and represents a druggable target for therapeutic intervention. |
| Clinical impact of prospective circulating tumour DNA testing for minimal residual disease in colorectal cancer: the INTERCEPT programme experience.
ctDNA testing provides a framework for risk stratification and defines temporal windows that may inform future interventional strategies. Prospective interventional studies are required to define clinical utility and optimal implementation. |
| Hypothermic oxygenated and normothermic machine perfusion mitigate innate systemic and hepatic inflammation after liver transplantation.
In a randomised controlled trial using human samples, HOPE and NMP differentially modulate hepatic and systemic immune responses, attenuating neutrophil-driven inflammation and promoting immune regulation after liver transplantation. |
| Hepatology |
| Reciprocal cross-species infection potential of human and domestic cat hepatitis B viruses.
Additionally, overexpression of cat orthologs of the proposed HBV cofactors EGFR and NRP1 did not rescue the infection. These findings suggest a marginal zoonotic risk of DCHBV for humans and support domestic cats as a potential immunocompetent animal model for HBV research. |
| The hepatic sinusoid as a regulatory niche: From cellular specialization to precision hepatology.
We define priorities for mapping disease-stage-specific human niches, restoring protective functions, developing composite biomarkers and standardizing translational platforms. The hepatic sinusoid is considered here as a tissue-level regulatory unit whose failure can be interrogated through coupled vascular, stromal, immune, metabolic and mechanical readouts. |
| J Hepatol |
| EBV-reactive KIR+ CX3CR1+ CD8+ T cells mediate liver transplantation tolerance.
Our study demonstrated a new immune tolerance mechanism mediated by KIR + CX3CR1 + CD8 + T cells and established the connection between viral infection and tolerance formation, providing new insights into tolerance-inductive strategies after transplantation. |
| Multi-target blood test for hepatocellular carcinoma early detection: a cross-sectional analysis of the prospective ALTUS study.
The mt-HBT had higher observed sensitivity than ultrasound for early-stage HCC, with a paired absolute difference of 44.4% (95% CI, 20.2-63.8); however, specificity did not meet the prespecified target. |
| Overall and Line-Specific Impact of Targeted Therapies in Advanced Biliary Tract Cancer After Chemoimmunotherapy Failure.
Matched targeted therapy was associated with improved outcomes after chemoimmunotherapy failure, particularly when delivered in second line. Early molecular profiling and access to matched agents may reduce missed treatment opportunities. Impact and implications This study was undertaken to address a clinically relevant gap whether the benefit of targeted therapies in molecularly selected advanced biliary tract cancer is maintained in real-world practice after chemoimmunotherapy failure, and whether timing of administration matters. The findings are important for clinicians, multidisciplinary teams, and patients because they show that matched targeted therapies were associated with longer survival, particularly when delivered in second line, while fewer than half of eligible patients ultimately received them in routine care. These results support early and systematic molecular profiling, ideally before first-line progression, to improve the likelihood that patients can access matched therapy while still fit for treatment. Given the retrospective design and the limited size of some molecular subgroups, these findings should be viewed as practice-informing and hypothesis-generating, while also highlighting the need for prospective validation and health-system strategies to improve access to precision oncology. |
| Survival outcomes after liver transplantation in acute-on-chronic liver failure: A prospective study.
ClinicalTrials. gov number, NCT04613921. |
Plenty of the editorials are available as full text through the publisher website using the provided link
| Aliment Pharmacol Ther |
|---|
| Editorial: Beyond the Matrix-Upadacitinib in Real-World Refractory Crohn's Disease. |
| Review Article: Cancer Surveillance for Early Detection of Liver Cancer in Patients with HBV Infection.
A risk-adapted approach should separate estimation of future HCC risk from surveillance and early-detection testing. Guideline-eligible patients should undergo surveillance every 6 months, while emerging biomarker, imaging and artificial-intelligence approaches remain adjunctive or investigational pending further HBV-specific validation. |
| Clin Gastroenterol Hepatol |
| Artificial Intelligence in MASLD: A Three-Level Framework Across Clinical, Health-System, and Policy Decisions.
No randomized trial has yet demonstrated that AI-guided management improves clinical outcomes in MASLD, while governance, transparency, and equity frameworks remain underdeveloped. Realizing the clinical value of AI will require prospective multicenter studies embedded within clearly defined MASLD care decisions, validation across genetically and socioeconomically diverse populations and health-system settings, standardized reporting and risk-of-bias assessment, and sustained attention to implementation, governance, and equity. |
| Microscopic Colitis Beyond Histology: Biomarkers and Candidate Endotypes.
Moreover, artificial intelligence-driven multimodal approaches may ultimately complement morphological assessment, improve patient characterisation and support the prediction of treatment response. We further define the validation steps required to translate emerging biological signatures into clinically meaningful endotypes and precision medicine. |
| Modern Diagnosis and Management of Acid-Related Disorders.
Also, diagnosis and therapy are increasingly being personalized based on symptom profile and adjunct diagnostic data from an increasingly complex armamentarium of modalities. Therapeutic algorithms demonstrate the appropriate use of many of the technologies noted above in the care of patients with acid-related disorders. |
| Pay Gap Persists for Women in Academic Gastroenterology: An Analysis of the AAMC Salary Database 2020-2025. |
| Gastroenterology |
| Global burden of liver disease: 2026 update.
The escalating burden of MASLD, the growing interplay of metabolic disease and alcohol use, and persistent gaps in viral hepatitis diagnosis and treatment underscore the urgent need for integrated prevention, early detection, and equitable access to evidence-based liver care. This review provides an updated global assessment of the burden of liver disease, highlighting widening regional disparities, and outlining priorities and strategies for reducing its worldwide impact. |
| Gut |
| Metastatic pancreatic cancer: from human disease to preclinical modelling.
Finally, based on the current knowledge of this disease, we discuss existing limitations and future opportunities for advancing precision oncology approaches. These efforts may open promising avenues for the development of more effective clinical strategies aimed at mitigating metastasis in PDAC. |
| Regulatory T cells in autoimmune liver diseases.
We further evaluate current and emerging Treg-targeted therapeutic strategies, ranging from restoration of Treg abundance and function to disease-specific modulation of Treg responses, together with the major challenges to their clinical translation. By integrating these findings, we provide a disease-dependent and context-dependent framework for understanding Treg dysregulation in AILDs and identify key priorities for future mechanistic and translational research. |
| Rewinding the gut clock: from chronodisruption to targeted therapies.
Advances in research on rhythmic metabolites and interorgan metabolic coupling offer promising opportunities for understanding systemic circadian coordination. Overall, reinforcing circadian alignment holds potential for preventing and treating metabolic and GI diseases associated with modern lifestyle-induced chronodisruption. |
| J Hepatol |
| B-cells on the rise: Serum IgA Identifies a High-Risk Biological Phenotype in MASLD. |
| When containment fails: β-adrenergic disruption of the gut-liver barrier in cirrhosis. |
misc publications eg case reports, tools of the trade, images of the month, etc…
| Am J Gastroenterol |
|---|
| 2025 CME Information. |
| Calendar of Courses, Symposiums and Conferences. |
| Correction to: Spatiotemporal Study of a Risk-Stratification Epigenetic-Based Biomarker Assay in Patients With Barrett Esophagus. |
| Endoscopic Resection of a Rare Colonic Plasmacytoma. |
| Clin Gastroenterol Hepatol |
| From Gut to Brain: Integrating Gastropsychology Training Into Gastroenterology Fellowship. |
| Guselkumab Versus Risankizumab for Ulcerative Colitis: Real-World Comparison of Post-Induction Outcomes. |
| The Data Deluge: Balancing Information Overload and Evidence-Based Medicine in Gastroenterology Fellowship. |
| Endoscopy |
| A novel device-assisted endoscopic ultrasonography-guided single balloon-occluded gastrojejunostomy bypass with a three-dimensional-printed three-way connector. |
| A rare case of curative endoscopic submucosal dissection of a duodenal gastrinoma revealed by Zollinger-Ellison syndrome. |
| Aligning with the Digestive Cancers Europe-informed domain-specific large language models for readable and reliable patient education in gastric cancer prevention. |
| Antegrade pancreatoscopy-guided laser recanalization of a completely occluded pancreaticojejunostomy anastomosis. |
| Cholangioscopy-targeted, ultrasound-monitored needle puncture for complete bilioenteric anastomotic occlusion in a 1-year-old liver transplant recipient. |
| Comments on the cumulative colorectal mucosal exposure area as a quality indicator. |
| Dental floss-assisted detachable loop ligation followed by snare resection of a giant pedunculated duodenal adenoma. |
| Detective flow imaging-assisted endoscopic ultrasound-guided radiofrequency ablation of hepatocellular carcinoma adjacent to the inferior vena cava. |
| Endoscopic full-thickness resection of a colonic granular cell tumour using a full-thickness resection device system. |
| Endoscopic removal of a date pit masquerading as an appendicolith in a young patient with recurrent right lower quadrant pain. |
| Endoscopic submucosal dissection versus transanal surgery for rectal neoplasia: are we asking the right question? |
| Endoscopic ultrasound suggestive of a gastric duplication cyst presenting as a gastric subepithelial tumor-like lesion. |
| Endoscopic ultrasound-guided duodenojejunostomy for recurrent malignant duodenal obstruction after surgical gastrojejunostomy. |
| Endoscopic ultrasound-guided transvariceal coil anchoring combined with sandwich injection for giant isolated gastric varices type 1. |
| Endoscopy E-Videos - recently published. |
| Furoshiki traction: broad-area lifting in colorectal endoscopic submucosal dissection with clip-with-line pulley securing. |
| Gastric peroral endoscopic pyloromyotomy for postesophagectomy gastroparesis. |
| Gel-immersion peroral cholangioscopy facilitates targeted sampling of a liver abscess. |
| Hard method, soft inputs: the polypoid signal in T1 colorectal cancer after endoscopic resection. |
| Modified peroral endoscopic septotomy using a thin-needle high-pressure waterjet knife for short-septum Zenker's diverticulum. |
| Pitfall of endoscopic ultrasound-guided rendezvous: sphincterotomy-related perforation caused by misidentification of the guidewire exit. |
| Planned delayed retrieval of a migrated stent from an infected biloma via an endosonographically created duodenal route. |
| Prophylactic clipping after colorectal endoscopic submucosal dissection: a meta-analytic benefit contingent on one trial with high baseline risk. |
| Prophylactic clipping after colorectal endoscopic submucosal dissection: separating efficacy from routine implementation. |
| Re-evaluating the risks and benefits of gastric fundal mucosal ablation for tolerability enhancement before endoscopic sleeve gastroplasty. |
| Refractory hemobilia following liver transplantation. |
| Salvage double-guidewire-assisted endoscopic ultrasound-guided rendezvous drainage for disrupted pancreatojejunostomy. |
| Utility of narrow-band imaging plus texture and color enhancement imaging mode in the evaluation of a rectal superficially serrated adenoma overlying a surgical scar. |
| You show me the incentive, I'll show you the outcome: can AI-supported "resect and discard" save carbon dioxide emissions and healthcare costs? |
| Gastroenterology |
| A Cracked-Mud Duodenum in a Man With Weight Loss and Arthralgia. |
| A Rare Cause of Recurrent Vomiting: Diagnosis and Management. |
| Stating the Head, Playing the Changes: A Jazz Reading of Rome V. |
| Gastrointest Endosc |
| Computed tomography-guided iohexol contrast imaging for assessing ductal communication in pancreatic cystic lesions. |
| Endoscopic Resection of a Giant Mucin-Rich Traditional Serrated Adenoma at Colorectal Anastomosis. |
| Endoscopic Ultrasound with Water Insufflation Aids Diagnosis of Periampullary Diverticulum Causing a Transient Distal Biliary Stricture: A Case Report. |
| Endoscopic Vacuum Therapy Successfully Treats a Large Radiation-Related Low Rectal Anastomotic Ulcer After Local Excision for Rectal Cancer. |
| Gastric Intramural Squamous Cell Carcinoma Mimicking a Fundic Subepithelial Tumor After Curative Esophageal ESD. |
| Rescue Treatment with intraluminal endoscopic vacuum therapy for Ileal Pouch-Anal Anastomotic Dehiscence in a Young Patient with Ulcerative Colitis (with Video). |
| Gut |
| Beyond liver fibrosis: uncovering systemic risk in MASLD. |
| Checkpoints in circulation: extracellular vesicles can predict immunotherapy response and resistance in hepatocellular carcinoma. |
| GLP-1 receptor agonists versus DPP-4 inhibitors after curative resection of hepatocellular carcinoma in patients with type 2 diabetes. |
| Incidental duodenal lesions found in a patient being investigated for reflux and abdominal pain. |
| When colonic ulcers meet destructive nasal lesions and cutaneous ulceration: a diagnostic dilemma. |
| Hepatology |
| Therapies for alcohol use disorder in alcohol-associated hepatitis clinical trials: Integrated trial design with a composite clinical outcome as the primary endpoint. |
Letters to the editors and authors’ replies
| Aliment Pharmacol Ther |
|---|
| Editorial: MetALD-ALD Prediction Index-A Scalable Biomarker for Alcohol Phenotyping Beyond PEth. Authors' Reply. |
| Letter: From Genetic Association to Clinical Prediction in Chronic Hepatitis D. |
| Letter: P-CAB Versus PPI for Antithrombotic Gastroprotection: The Importance of Longitudinal Treatment Dynamics-Authors' Reply. |
| Letter: Proton Pump Inhibitor Prescribing in Autoimmune Gastritis-From Real-World Exposure to Indication-Driven Reassessment. |
| Letter: Sinonasal Microbiota: The Immunological Link Between Eosinophilic Oesophagitis and Chronic Rhinosunisitis? |
| Letter: Temporal Alignment of Proton Pump Inhibitor Exposure and Gastric Neuroendocrine Neoplasm Risk in Autoimmune Gastritis. Authors' Reply. |
| Letter: Timing Matters-Interpreting Colonic Gas Reduction With Gel-Forming Fibres. |
| Letter: What Does MAPI-Informed ALD Classification Capture? |
| Clin Gastroenterol Hepatol |
| Anchored Exposures, Competing Risks, and Impossible Statistics: Mental Health-Hepatocellular Carcinoma in Veterans. |
| Rebuttal to "Anchored exposures, competing risks and impossible statistics: mental health-HCC in Veterans". |
| Gastroenterology |
| A Common Time Horizon for Fecal Hemoglobin-Guided Surveillance Projections. |
| Finishing the Unfinished Agenda: Monoantibiotic Strategies for Helicobacter pylori in the Era of Rising Resistances. |
| Precision Without Relevance: The Limits of Genetic Testing in Common Liver Diseases. |
| Gut |
| Clarifying the clinical utility of extracellular-vesicle immune checkpoints in HCC. |
| Diabetes status stratifies the association between gut microbiome and sarcopenia. |
| Symptom-based classification of paediatric disorders of gut-brain interaction in early childhood: safeguarding against missed intestinal pseudo-obstruction. |
| J Hepatol |
| From Defining to Understanding Porto-Sinusoidal Vascular Disorder. |
| Precision support requires modifiable targets and inclusive reach in STOP-C. |